Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a …

WS Redfern, L Carlsson, AS Davis… - Cardiovascular …, 2003 - academic.oup.com
Objective: To attempt to determine the relative value of preclinical cardiac electrophysiology
data (in vitro and in vivo) for predicting risk of torsade de pointes (TdP) in clinical use …

[HTML][HTML] Toward a broader view of mechanisms of drug cardiotoxicity

P Mamoshina, B Rodriguez, A Bueno-Orovio - Cell Reports Medicine, 2021 - cell.com
Cardiotoxicity, defined as toxicity that affects the heart, is one of the most common adverse
drug effects. Numerous drugs have been shown to have the potential to induce lethal …

[PDF][PDF] The pharmacological treatment of urinary incontinence

KE Andersson, R Appell, LD Cardozo, C Chapple… - BJU …, 1999 - academia.edu
The pharmacological treatment of urinary incontinence Page 1 BJU International (1999), 84,
923–947 REVIEW The pharmacological treatment of urinary incontinence K.-E …

The problems of anticholinergic adverse effects in older patients

M Feinberg - Drugs & aging, 1993 - Springer
The old saying 'red as a beet, dry as a bone, blind as a bat, hot as a hare, mad as a hatter'is
often quoted when describing the autonomic effects of drugs that block the muscarinic …

Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors

D Zeltser, D Justo, A Halkin, V Prokhorov, K Heller… - Medicine, 2003 - journals.lww.com
Numerous medications, including drugs prescribed for noncardiac indications, can lead to
QT prolongation and trigger torsade de pointes. Although this complication occurs only …

Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes

B Darpö - European Heart Journal Supplements, 2001 - academic.oup.com
The incidence of drug-induced proarrhythmias in the general population is largely unknown.
Knowledge regarding incidence and risk factors is mainly derived from studies during …

QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience

F De Ponti, E Poluzzi, N Montanaro - European journal of clinical …, 2000 - Springer
Background: Evidence has accrued that several non-cardiac drugs may prolong cardiac
repolarisation (hence, the QT interval of the surface electrocardiogram) to such a degree that …

Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence

KE Andersson, CR Chapple, L Cardozo… - Current opinion in …, 2009 - journals.lww.com
Pharmacological treatment of overactive bladder: report from... : Current Opinion in Urology
Pharmacological treatment of overactive bladder: report from the International Consultation on …

Organising evidence on QT prolongation and occurrence of Torsades de Pointes with non-antiarrhythmic drugs: a call for consensus

F De Ponti, E Poluzzi, N Montanaro - European journal of clinical …, 2001 - Springer
Background: The growing list of non-antiarrhythmic drugs associated with QT prolongation
and the relevant regulatory interventions have generated concern for two reasons. First, QT …

[HTML][HTML] Prevention of urinary and fecal incontinence in adults.

T Shamliyan, J Wyman, DZ Bliss, RL Kane… - Evidence report …, 2007 - europepmc.org
Objectives To assess the prevalence of and risk factors for urinary (UI) and fecal (FI)
incontinence in adults in long-term care (LTC) settings and in the community, the …